TAZZA, FRANCESCO
 Distribuzione geografica
Continente #
EU - Europa 487
AS - Asia 116
NA - Nord America 110
SA - Sud America 18
Continente sconosciuto - Info sul continente non disponibili 18
AF - Africa 1
Totale 750
Nazione #
IT - Italia 477
US - Stati Uniti d'America 102
SG - Singapore 46
VN - Vietnam 27
CN - Cina 23
BR - Brasile 11
BD - Bangladesh 6
CA - Canada 5
FR - Francia 5
HK - Hong Kong 5
AR - Argentina 3
MX - Messico 2
NL - Olanda 2
PK - Pakistan 2
SA - Arabia Saudita 2
AZ - Azerbaigian 1
CL - Cile 1
CY - Cipro 1
DE - Germania 1
EC - Ecuador 1
GB - Regno Unito 1
JO - Giordania 1
JP - Giappone 1
MA - Marocco 1
NI - Nicaragua 1
OM - Oman 1
PE - Perù 1
PY - Paraguay 1
RU - Federazione Russa 1
Totale 732
Città #
Genoa 312
Vado Ligure 83
Rapallo 35
Genova 30
Ashburn 25
Singapore 25
San Jose 16
Ho Chi Minh City 11
Hanoi 6
Beijing 5
Hong Kong 5
Los Angeles 5
Savona 5
Council Bluffs 4
Lauterbourg 4
Lyndhurst 4
Boardman 2
Citrus Heights 2
Haiphong 2
Mexico City 2
Miami 2
Milwaukee 2
Montreal 2
New York 2
Riyadh 2
Spokane 2
Verona 2
Amman 1
Amsterdam 1
Anchorage 1
Asunción 1
Baku 1
Banning 1
Bari 1
Biên Hòa 1
Buenos Aires 1
Buffalo 1
Calgary 1
Catania 1
Chambly 1
Charlotte 1
Chemnitz 1
Chicago 1
City of London 1
Columbus 1
Cotia 1
Curitiba 1
Dallas 1
Dhaka 1
Faisalabad 1
Florence 1
Fortaleza 1
Goiânia 1
Granite City 1
Guarulhos 1
Hortolândia 1
Itapipoca 1
Jacksonville 1
Karachi 1
Lafayette 1
Limassol 1
Loja 1
Lomas de Zamora 1
Managua 1
Middletown 1
Minneapolis 1
Mission Viejo 1
Muscat 1
Novoural'sk 1
Orlando 1
Paris 1
Parobé 1
Philadelphia 1
Phoenix 1
Phủ Lý 1
Pietra Ligure 1
Posadas 1
Queens 1
Quảng Ngãi 1
Rio de Janeiro 1
Rome 1
Santa Clara 1
Santiago 1
Scarborough 1
Sterling 1
Stockton 1
Tampa 1
Thái Nguyên 1
Tietê 1
Tokyo 1
Tramandaí 1
Tétouan 1
Totale 662
Nome #
Case Report: Post-COVID-19 Vaccine Recurrence of Guillain-Barré Syndrome Following an Antecedent Parainfectious COVID-19-Related GBS 128
Central vein sign and diffusion MRI differentiate microstructural features within white matter lesions of multiple sclerosis patients with comorbidities 126
Predictors of Ocrelizumab Effectiveness in Patients with Multiple Sclerosis 115
In-vivo characterization of macro- and microstructural injury of the subventricular zone in relapsing-remitting and progressive multiple sclerosis 112
COVID-19 in a MS patient treated with ocrelizumab: does immunosuppression have a protective role? 103
Personalizing ocrelizumab treatment in Multiple Sclerosis: What can we learn from Sars-Cov2 pandemic? 97
Multiparametric Characterization and Spatial Distribution of Different MS Lesion Phenotypes 69
Totale 750
Categoria #
all - tutte 3.235
article - articoli 3.235
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 6.470


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/202221 0 0 0 3 2 1 0 5 1 4 1 4
2022/202351 4 4 0 6 5 6 0 1 7 0 10 8
2023/202485 6 5 6 10 2 11 18 1 0 9 2 15
2024/2025204 19 12 7 13 21 23 11 41 17 9 20 11
2025/2026353 48 4 29 24 55 12 50 21 33 34 23 20
2026/202723 23 0 0 0 0 0 0 0 0 0 0 0
Totale 750